Free. Unsubscribe any time.
GILEAD SCIENCES, INC. (GILD)
GILEAD SCIENCES, INC. filed 65 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 111 transactions and 1,059,822 shares. None carries the SEC's AFF10B5ONE flag; all 65 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-16, came on the same day as the one before it (2026-09-16) and reports 3 transactions against 1 in the filing before it.
- The sales it reports total 3,000 shares, the same as the 3,000 in the filing before it.
- Its 65 plan statements rank 71st of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 65 filings on file run from 2025-01-16 to 2026-09-16, and state 9 plan adoption dates, from 2024-08-29 to 2026-05-27.
Trades in GILEAD SCIENCES, INC. 111
- Dickinson Andrew D — 2025-01-15 · S · 2,500 shares
- Dickinson Andrew D — 2025-01-31 · S · 142,180 shares
- Dickinson Andrew D — 2025-02-12 · S · 137,676 shares
- Dickinson Andrew D — 2025-02-18 · S · 2,500 shares
- Dickinson Andrew D — 2025-03-10 · S · 4,916 shares
- Dickinson Andrew D — 2025-03-10 · S · 13,013 shares
- Dickinson Andrew D — 2025-03-17 · S · 2,500 shares
- Dickinson Andrew D — 2025-04-15 · S · 2,500 shares
- Dickinson Andrew D — 2025-05-15 · S · 2,500 shares
- Mercier Johanna — 2025-05-22 · S · 12,500 shares
- Mercier Johanna — 2025-05-22 · S · 12,500 shares
- Mercier Johanna — 2025-05-22 · S · 3,000 shares
Adoption dates in GILEAD SCIENCES, INC. 9
- 2024-08-29 — stated in 24 filings
- 2025-02-13 — stated in 2 filings
- 2025-02-20 — stated in 17 filings
- 2025-02-28 — stated in 14 filings
- 2025-08-13 — stated in 1 filing
- 2025-08-27 — stated in 1 filing
- 2026-02-25 — stated in 4 filings
- 2026-05-20 — stated in 1 filing
- 2026-05-27 — stated in 1 filing
Results prints in GILEAD SCIENCES, INC. 7
- 2025-02-11
- 2025-04-24
- 2025-08-07
- 2025-10-30
- 2026-02-10
- 2026-05-07
- 2026-08-04
Trades before a print in GILEAD SCIENCES, INC. 6
- 1 day before the 2026-08-04 print — 2026-08-03 · S · O'Day Daniel Patrick · 6,700 shares
- 1 day before the 2026-08-04 print — 2026-08-03 · S · O'Day Daniel Patrick · 7,700 shares
- 1 day before the 2026-08-04 print — 2026-08-03 · S · O'Day Daniel Patrick · 600 shares
- 2 days before the 2025-10-30 print — 2025-10-28 · S · O'Day Daniel Patrick · 7,978 shares
- 2 days before the 2025-10-30 print — 2025-10-28 · S · O'Day Daniel Patrick · 2,022 shares
- 5 days before the 2026-02-10 print — 2026-02-05 · S · O'Day Daniel Patrick · 115,640 shares
- 9 days before the 2025-04-24 print — 2025-04-15 · S · Dickinson Andrew D · 2,500 shares
- 9 days before the 2026-05-07 print — 2026-04-28 · S · O'Day Daniel Patrick · 6,950 shares
- 9 days before the 2026-05-07 print — 2026-04-28 · S · O'Day Daniel Patrick · 3,050 shares
- 10 days before the 2025-08-07 print — 2025-07-28 · S · O'Day Daniel Patrick · 1,655 shares
- 10 days before the 2025-08-07 print — 2025-07-28 · S · O'Day Daniel Patrick · 8,345 shares
- 11 days before the 2025-02-11 print — 2025-01-31 · S · Dickinson Andrew D · 142,180 shares
Interval to GILEAD SCIENCES, INC.’s next reported results date
How the interval and sources are counted →
- 6within 5 days
- 11within 10 days
- 1shortest, days
- 19no later print
- Dickinson Andrew D 2025-04-15 · S · 9 days before the 2025-04-24 print · Chief Financial Officer
- O'Day Daniel Patrick 2025-07-28 · S · 10 days before the 2025-08-07 print · Chairman & CEO
- O'Day Daniel Patrick 2025-07-28 · S · 10 days before the 2025-08-07 print · Chairman & CEO
- O'Day Daniel Patrick 2025-10-28 · S · 2 days before the 2025-10-30 print · Chairman & CEO
- O'Day Daniel Patrick 2025-10-28 · S · 2 days before the 2025-10-30 print · Chairman & CEO
- O'Day Daniel Patrick 2026-02-05 · S · 5 days before the 2026-02-10 print · Chairman & CEO
- O'Day Daniel Patrick 2026-04-28 · S · 9 days before the 2026-05-07 print · Chairman & CEO
- O'Day Daniel Patrick 2026-04-28 · S · 9 days before the 2026-05-07 print · Chairman & CEO
- O'Day Daniel Patrick 2026-08-03 · S · 1 day before the 2026-08-04 print · Chairman & CEO
- O'Day Daniel Patrick 2026-08-03 · S · 1 day before the 2026-08-04 print · Chairman & CEO
- O'Day Daniel Patrick 2026-08-03 · S · 1 day before the 2026-08-04 print · Chairman & CEO
Adoption dates GILEAD SCIENCES, INC. states
- 2024-08-29 in 24 filings
- 2025-02-13 in 2 filings
- 2025-02-20 in 17 filings
- 2025-02-28 in 14 filings
- 2025-08-13 in 1 filing
- 2025-08-27 in 1 filing
- 2026-02-25 in 4 filings
- 2026-05-20 in 1 filing
- 2026-05-27 in 1 filing
Filing text: “10b5-1 trading plan adopted on February 20, 2025”
Reported results dates on file
- 2025-02-11
- 2025-04-24
- 2025-08-07
- 2025-10-30
- 2026-02-10
- 2026-05-07
- 2026-08-04
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.